1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.2.1 INCLUSIONS AND EXCLUSIONS 42
1.2.2 MARKETS COVERED 43
FIGURE 1 IN VITRO TOXICOLOGY TESTING MARKET 43
1.2.3 YEARS CONSIDERED FOR THE STUDY 44
1.3 CURRENCY 44
1.4 STAKEHOLDERS 44
1.5 LIMITATIONS 45
1.6 SUMMARY OF CHANGES 45

2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
FIGURE 2 RESEARCH DESIGN 46
2.1.1 SECONDARY RESEARCH 46
2.1.1.1 Key data from secondary sources 47
2.1.2 PRIMARY RESEARCH 48
2.1.2.1 Key data from primary sources 48
2.1.2.2 Breakdown of primaries 49
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION & VALIDATION APPROACH 49
FIGURE 4 MARKET SIZE APPROACH 51
FIGURE 5 BOTTOM-UP APPROACH 51
2.3 DATA TRIANGULATION APPROACH 52
FIGURE 6 DATA TRIANGULATION METHODOLOGY 52
2.4 MARKET SHARE ESTIMATION 53
2.5 ASSUMPTIONS FOR THE STUDY 53

3 EXECUTIVE SUMMARY 54
FIGURE 7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,

2020 VS. 2025 (USD MILLION) 54
FIGURE 8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020 VS. 2025 (USD MILLION) 55
FIGURE 9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,

2020 VS. 2025 (USD MILLION) 56
FIGURE 10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,

2020 VS. 2025 (USD MILLION) 56
FIGURE 11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,

2020 VS. 2025 (USD MILLION) 57
FIGURE 12 GEOGRAPHIC ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 58

4 PREMIUM INSIGHTS 59
4.1 IN VITRO TOXICOLOGY TESTING MARKET OVERVIEW 59
FIGURE 13 OPPOSITION TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING MARKET GROWTH 59
4.2 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 60
FIGURE 14 CELLULAR ASSAYS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC IN VITRO TOXICOLOGY TESTING MARKET IN 2019 60
4.3 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 15 CHINA SHOWS THE HIGHEST REVENUE GROWTH DURING THE FORECAST PERIOD 61
4.4 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION (2018-2025) 62
FIGURE 16 EUROPE WILL CONTINUE TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET IN 2025 62
4.5 IN VITRO TOXICOLOGY TESTING MARKET: DEVELOPED VS. DEVELOPING MARKETS 63
FIGURE 17 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD 63

5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 64
FIGURE 18 IN VITRO TOXICOLOGY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 64
5.2.1 MARKET DRIVERS 65
5.2.1.1 Opposition to animal testing 65
5.2.1.2 Technological advancements 66
5.2.1.3 R&D on early-stage toxicity detection 66
5.2.2 MARKET RESTRAINTS 67
5.2.2.1 Reluctance of regulatory authorities to consider alternative methods for proving safety and efficacy 67
5.2.2.2 Failure to establish the intricacies of in vivo conditions 67
5.2.2.3 Lack of in vitro models to study complex endpoints 68
5.2.3 MARKET OPPORTUNITIES 68
5.2.3.1 Increasing focus on drug discovery and personalized medicine using in vitro methods 68
5.2.3.2 Increasing number of toxicology databases 69
5.2.4 MARKET CHALLENGES 70
5.2.4.1 Dearth of skilled professionals 70

6 INDUSTRY INSIGHTS 71
6.1 INTRODUCTION 71
6.2 INDUSTRY TRENDS 71
6.2.1 INCREASING FOCUS ON PREDICTIVE TOXICOLOGY 71
6.3 SUPPLY CHAIN ANALYSIS 72
FIGURE 19 SUPPLY CHAIN ANALYSIS: IN VITRO TOXICOLOGY TESTING MARKET 72
6.4 REGULATORY COMMITTEE ACTIVITIES 72
6.4.1 MAJOR STAKEHOLDERS 73
6.4.2 KEY INFLUENCERS 73
6.5 COVID-19 IMPACT ON THE IN VITRO TOXICOLOGY MARKET 74
FIGURE 20 IMPACT OF COVID-19 ON IN VITRO TOXICOLOGY TESTING MARKET 75

7 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE 76
7.1 INTRODUCTION 77
7.2 COVID-19 IMPACT, BY PRODUCT & SERVICE 77
FIGURE 21 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 77
TABLE 1 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2017-2019 (USD MILLION) 78
TABLE 2 IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE,
2020-2025 (USD MILLION) 78
7.3 CONSUMABLES 79
7.3.1 CONSUMABLES TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 79
TABLE 3 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 80
TABLE 4 IN VITRO TOXICOLOGY TESTING CONSUMABLES MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 80
7.4 ASSAYS 81
TABLE 5 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 81
TABLE 6 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 82
TABLE 7 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 82
TABLE 8 IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 83
7.4.1 BACTERIAL TOXICITY ASSAYS 83
7.4.1.1 Bacterial assays dominate the market as they are the most widely adopted assay type across industries 83
TABLE 9 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 84
TABLE 10 BACTERIAL TOXICITY ASSAYS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 84
7.4.2 ENZYME TOXICITY ASSAYS 85
7.4.2.1 Enzyme toxicity assays are increasingly used for endocrine-disrupting studies—a key factor driving market growth 85
TABLE 11 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 85
TABLE 12 ENZYME TOXICITY ASSAYS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 86
7.4.3 CELL-BASED ELISA & WESTERN BLOTS 86
7.4.3.1 Cell-based assays are cost-effective, owing to which they are witnessing increasing adoption in drug discovery 86
TABLE 13 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 87
TABLE 14 CELL-BASED ELISA & WESTERN BLOTS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 88
7.4.4 RECEPTOR-BINDING ASSAYS 88
7.4.4.1 Receptor-binding assays are well-suited for high-throughput formats, a key factor driving the adoption of these products 88
TABLE 15 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 89
TABLE 16 RECEPTOR-BINDING ASSAYS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 89
7.4.5 TISSUE CULTURE ASSAYS 90
7.4.5.1 Tissue culture assays offer the advantage of mimicking in vivo tissue architecture 90
TABLE 17 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 90
TABLE 18 TISSUE CULTURE ASSAYS MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 91
7.4.6 OTHER ASSAYS 91
TABLE 19 OTHER ASSAYS MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 92
TABLE 20 OTHER ASSAYS MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 92
7.5 EQUIPMENT 93
7.5.1 FULLY AUTOMATED EQUIPMENT IS WITNESSING GROWING ADOPTION IN RESEARCH 93
TABLE 21 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 94
TABLE 22 IN VITRO TOXICOLOGY TESTING EQUIPMENT MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 94
7.6 SOFTWARE 95
7.6.1 SOFTWARE TOOLS ARE VITAL IN REDUCING ANALYSIS TIMES AND MANAGING LARGE AMOUNTS OF DATA GENERATED IN OPERATIONS 95
TABLE 23 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 95
TABLE 24 IN VITRO TOXICOLOGY TESTING SOFTWARE MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 96
7.7 SERVICES 96
7.7.1 LACK OF INFRASTRUCTURE AND EXPERTISE HAVE DRIVEN RELIANCE ON SERVICE PROVIDERS 96
TABLE 25 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 97
TABLE 26 IN VITRO TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 98

8 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST 99
8.1 INTRODUCTION 100
FIGURE 22 ORGAN TOXICITY TESTING TO REGISTER THE HIGHEST GROWTH IN THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 100
TABLE 27 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 101
TABLE 28 IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 101
8.2 ADME (ABSORPTION, DISTRIBUTION, METABOLISM, & EXCRETION) TESTING 102
8.2.1 ADME TESTING TO DOMINATE THE IN VITRO TOXICOLOGY TESTING MARKET DURING THE FORECAST PERIOD 102
TABLE 29 ADME TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 103
TABLE 30 ADME TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 103
8.3 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING 104
8.3.1 SKIN IRRITATION, CORROSION, AND SENSITIZATION ARE MAJOR ENDPOINTS STUDIED IN THE COSMETICS INDUSTRY 104
TABLE 31 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET,
BY COUNTRY, 2017-2019 (USD MILLION) 105
TABLE 32 SKIN IRRITATION, CORROSION, & SENSITIZATION TESTING MARKET,
BY COUNTRY, 2020-2025 (USD MILLION) 105
8.4 GENOTOXICITY TESTING 106
8.4.1 MORE GENOTOXICITY TESTS ARE REVIEWED AND VALIDATED BY REGULATORY AUTHORITIES THAN ANY OTHER ENDPOINT— A KEY DRIVER FOR MARKET GROWTH 106
TABLE 33 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 107
TABLE 34 GENOTOXICITY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 107
8.5 CYTOTOXICITY TESTING 108
8.5.1 RISING NEED FOR BIOSAFETY IS LARGELY CONTRIBUTING TO THE GROWTH OF THE CYTOTOXICITY TESTING MARKET 108
TABLE 35 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 109
TABLE 36 CYTOTOXICITY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 109
8.6 OCULAR TOXICITY TESTING 110
8.6.1 IN VITRO AND EX VIVO METHODS ARE GAINING HIGH RECOGNITION FOR OCULAR TOXICITY TESTING 110
TABLE 37 OCULAR TOXICITY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 110
TABLE 38 OCULAR TOXICITY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 111
8.7 ORGAN TOXICITY TESTING 111
8.7.1 HIGH-CONTENT SCREENING AND CELL-BASED ASSAYS ARE USED TO DETECT ORGAN-SPECIFIC TOXICITY 111
TABLE 39 ORGAN TOXICITY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 112
TABLE 40 ORGAN TOXICITY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 112
8.8 PHOTOTOXICITY TESTING 113
8.8.1 VALIDATED NON-ANIMAL METHODS ARE USED TO EVALUATE THE PHOTOSAFETY OF COSMETICS, PHARMACEUTICALS, & CHEMICALS 113
TABLE 41 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 113
TABLE 42 PHOTOTOXICITY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 114
8.9 DERMAL TOXICITY TESTING 114
8.9.1 IN VITRO METHODS FOR DERMAL TOXICITY TESTING ARE EXPECTED TO GAIN RECOGNITION IN THE COMING YEARS 114
TABLE 43 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 115
TABLE 44 DERMAL TOXICITY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 115
8.10 OTHER TOXICITY ENDPOINTS & TESTS 116
TABLE 45 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 116
TABLE 46 OTHER TOXICITY ENDPOINTS & TESTS MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 117

9 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY 118
9.1 INTRODUCTION 119
FIGURE 23 TOXICOGENOMICS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 119
TABLE 47 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 119
TABLE 48 IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 120
9.2 CELL CULTURE TECHNOLOGIES 120
9.2.1 CELL- & TISSUE-BASED TECHNOLOGIES ARE THE MOST WIDELY ADOPTED IN IN VITRO TESTING 120
TABLE 49 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2017-2019 (USD MILLION) 121
TABLE 50 IN VITRO TOXICOLOGY TESTING MARKET FOR CELL CULTURE TECHNOLOGIES, BY COUNTRY, 2020-2025 (USD MILLION) 122
9.3 HIGH-THROUGHPUT TECHNOLOGIES 122
9.3.1 INCREASING USE OF HIGH-CONTENT IMAGING TECHNOLOGIES IS DRIVING MARKET GROWTH 122
TABLE 51 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2017-2019 (USD MILLION) 123
TABLE 52 IN VITRO TOXICOLOGY TESTING MARKET FOR HIGH-THROUGHPUT TECHNOLOGIES, BY COUNTRY, 2020-2025 (USD MILLION) 124
9.4 TOXICOGENOMICS 124
9.4.1 IMPROVEMENTS IN PROTEOMIC TECHNOLOGIES ARE ENHANCING THE STUDY OF GENE & PROTEIN ACTIVITY DURING TOXICITY ANALYSIS 124
TABLE 53 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2017-2019 (USD MILLION) 125
TABLE 54 IN VITRO TOXICOLOGY TESTING MARKET FOR TOXICOGENOMICS,
BY COUNTRY, 2020-2025 (USD MILLION) 126

10 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY 127
10.1 INTRODUCTION 128
FIGURE 24 PHARMACEUTICALS & BIOPHARMACEUTICALS TO COMMAND THE LARGEST SHARE OF THE MARKET DURING THE FORECAST PERIOD 128
TABLE 55 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 128
TABLE 56 IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 129
10.2 COVID-19 IMPACT, BY INDUSTRY 129
10.3 PHARMACEUTICALS & BIOPHARMACEUTICALS 129
10.3.1 DRUG ATTRITION RATE IS LEADING TO THE HIGH ADOPTION OF IN VITRO TESTING ASSAYS IN THE EARLY STAGES OF DRUG DEVELOPMENT 129
TABLE 57 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 131
TABLE 58 PHARMACEUTICAL & BIOPHARMACEUTICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 131
10.4 COSMETICS & HOUSEHOLD PRODUCTS 132
10.4.1 BAN ON ANIMAL TESTING IS INCREASING THE ADOPTION OF IN VITRO ASSAYS FOR SAFETY TESTING 132
TABLE 59 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 133
TABLE 60 COSMETIC & HOUSEHOLD PRODUCT IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 133
10.5 FOOD 134
10.5.1 INCREASING FOCUS ON FOOD SAFETY IS DRIVING MARKET GROWTH 134
TABLE 61 TYPES OF TOXICOLOGICAL TESTS IN THE FOOD INDUSTRY 134
TABLE 62 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 135
TABLE 63 FOOD IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 136
10.6 CHEMICALS 136
10.6.1 INCREASING FOCUS ON ORGANOID-BASED IN VITRO APPROACHES FOR CHEMICAL TESTING IS PROPELLING THE MARKET 136
TABLE 64 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 137
TABLE 65 CHEMICAL IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 138

11 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD 139
11.1 INTRODUCTION 140
FIGURE 25 IN SILICO MODELS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 140
TABLE 66 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 140
TABLE 67 IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 141
11.2 CELLULAR ASSAYS 141
11.2.1 DEVELOPMENT OF MULTI-PARAMETER ASSAYS WILL PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES TO MARKET PLAYERS 141
TABLE 68 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS,
BY COUNTRY, 2017-2019 (USD MILLION) 142
TABLE 69 IN VITRO TOXICOLOGY TESTING MARKET FOR CELLULAR ASSAYS,
BY COUNTRY, 2020-2025 (USD MILLION) 143
11.3 BIOCHEMICAL ASSAYS 143
11.3.1 BIOCHEMICAL ASSAYS FIND WIDER APPLICATION IN THE PHARMACEUTICAL INDUSTRY AS COMPARED TO THE CHEMICAL AND FOOD INDUSTRIES 143
TABLE 70 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS,
BY COUNTRY, 2017-2019 (USD MILLION) 144
TABLE 71 IN VITRO TOXICOLOGY TESTING MARKET FOR BIOCHEMICAL ASSAYS,
BY COUNTRY, 2020-2025 (USD MILLION) 145
11.4 IN SILICO MODELS 145
11.4.1 IN SILICO MODELS ARE EXPECTED TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 145
TABLE 72 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS,
BY COUNTRY, 2017-2019 (USD MILLION) 146
TABLE 73 IN VITRO TOXICOLOGY TESTING MARKET FOR IN SILICO MODELS,
BY COUNTRY, 2020-2025 (USD MILLION) 147
11.5 EX-VIVO MODELS 147
11.5.1 EX-VIVO MODELS ARE WIDELY USED IN SKIN & EYE TOXICITY TESTING IN THE COSMETIC INDUSTRY 147
TABLE 74 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2017-2019 (USD MILLION) 148
TABLE 75 IN VITRO TOXICOLOGY TESTING MARKET FOR EX-VIVO MODELS, BY COUNTRY, 2020-2025 (USD MILLION) 148

12 IN VITRO TOXICOLOGY TESTING MARKET, BY REGION 149
12.1 INTRODUCTION 150
12.2 COVID-19 IMPACT, BY REGION 150
FIGURE 26 IN VITRO TOXICOLOGY TESTING MARKET: GEOGRAPHIC SNAPSHOT (2019) 151
TABLE 76 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2017-2019 (USD MILLION) 152
TABLE 77 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY REGION,
2020-2025 (USD MILLION) 152
12.3 EUROPE 152
FIGURE 27 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 154
TABLE 78 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 155
TABLE 79 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 155
TABLE 80 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 156
TABLE 81 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 156
TABLE 82 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 157
TABLE 83 EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 157
TABLE 84 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 158
TABLE 85 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 158
TABLE 86 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 159
TABLE 87 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 159
TABLE 88 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 159
TABLE 89 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 160
TABLE 90 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2024
(USD MILLION) 160
TABLE 91 EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 160
12.3.1 GERMANY 161
12.3.1.1 Germany holds the largest share of the European market 161
TABLE 92 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 162
TABLE 93 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 162
TABLE 94 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 162
TABLE 95 GERMANY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 163
TABLE 96 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 163
TABLE 97 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 164
TABLE 98 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 164
TABLE 99 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 165
TABLE 100 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 165
TABLE 101 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 165
TABLE 102 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 166
TABLE 103 GERMANY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 166
12.3.2 UK 166
12.3.2.1 Rising awareness, growing R&D, and increasing collaborations are key indicators of market growth in the UK 166
TABLE 104 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 167
TABLE 105 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 168
TABLE 106 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 168
TABLE 107 UK: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 169
TABLE 108 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 169
TABLE 109 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 170
TABLE 110 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 170
TABLE 111 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 170
TABLE 112 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 171
TABLE 113 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 171
TABLE 114 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 171
TABLE 115 UK: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 172
12.3.3 FRANCE 172
12.3.3.1 Research initiatives supported by the government are aiding market growth in France 172
TABLE 116 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 173
TABLE 117 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 173
TABLE 118 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 174
TABLE 119 FRANCE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 174
TABLE 120 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 175
TABLE 121 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 175
TABLE 122 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 176
TABLE 123 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 176
TABLE 124 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 176
TABLE 125 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 177
TABLE 126 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 177
TABLE 127 FRANCE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 177
12.3.4 ITALY 178
12.3.4.1 Growth in this market is mainly driven by the increasing
life science R&D 178
TABLE 128 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 178
TABLE 129 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 179
TABLE 130 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 179
TABLE 131 ITALY: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 180
TABLE 132 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 180
TABLE 133 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 181
TABLE 134 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 181
TABLE 135 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 181
TABLE 136 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 182
TABLE 137 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 182
TABLE 138 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 182
TABLE 139 ITALY: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 183
12.3.5 SPAIN 183
12.3.5.1 Spain's growing chemical industry is a major factor supporting the in vitro toxicology testing market in the country 183
TABLE 140 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 184
TABLE 141 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 184
TABLE 142 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 184
TABLE 143 SPAIN: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 185
TABLE 144 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 185
TABLE 145 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 186
TABLE 146 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 186
TABLE 147 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 186
TABLE 148 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 187
TABLE 149 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 187
TABLE 150 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 187
TABLE 151 SPAIN: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 188
12.3.6 REST OF EUROPE 188
TABLE 152 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 189
TABLE 153 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 189
TABLE 154 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2019 (USD MILLION) 190
TABLE 155 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020-2025 (USD MILLION) 190
TABLE 156 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 191
TABLE 157 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 191
TABLE 158 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2019 (USD MILLION) 192
TABLE 159 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION) 192
TABLE 160 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2019 (USD MILLION) 192
TABLE 161 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020-2025 (USD MILLION) 193
TABLE 162 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2019 (USD MILLION) 193
TABLE 163 REST OF EUROPE: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020-2025 (USD MILLION) 193
12.4 NORTH AMERICA 194
FIGURE 28 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA, 2017 194
FIGURE 29 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 195
TABLE 164 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2017-2019 (USD MILLION) 196
TABLE 165 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY, 2020-2025 (USD MILLION) 196
TABLE 166 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 196
TABLE 167 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 197
TABLE 168 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2019 (USD MILLION) 197
TABLE 169 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020-2025 (USD MILLION) 198
TABLE 170 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 198
TABLE 171 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 199
TABLE 172 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2019 (USD MILLION) 199
TABLE 173 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION) 200
TABLE 174 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2017-2019 (USD MILLION) 200
TABLE 175 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY, 2020-2025 (USD MILLION) 200
TABLE 176 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2017-2019 (USD MILLION) 201
TABLE 177 NORTH AMERICA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD, 2020-2025 (USD MILLION) 201
12.4.1 US 201
12.4.1.1 The US dominates the North American in vitro toxicology testing market due to a growing focus on biomarker discovery and research in the field of structure-based drug design 201
TABLE 178 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 202
TABLE 179 US: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 203
TABLE 180 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 203
TABLE 181 US: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 204
TABLE 182 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 204
TABLE 183 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 205
TABLE 184 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 205
TABLE 185 US: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 205
TABLE 186 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 206
TABLE 187 US: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 206
TABLE 188 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 206
TABLE 189 US: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 207
12.4.2 CANADA 207
12.4.2.1 Strong support for R&D and focus on developing new therapies will support market growth in Canada 207
TABLE 190 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 208
TABLE 191 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 208
TABLE 192 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 209
TABLE 193 CANADA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 209
TABLE 194 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 210
TABLE 195 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 210
TABLE 196 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 211
TABLE 197 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 211
TABLE 198 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 211
TABLE 199 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 212
TABLE 200 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 212
TABLE 201 CANADA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 212
12.5 ASIA PACIFIC 213
FIGURE 30 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET SNAPSHOT 214
TABLE 202 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2017-2019 (USD MILLION) 215
TABLE 203 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY COUNTRY,
2020-2025 (USD MILLION) 215
TABLE 204 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 215
TABLE 205 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 216
TABLE 206 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2017-2019 (USD MILLION) 216
TABLE 207 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE, 2020-2025 (USD MILLION) 217
TABLE 208 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 217
TABLE 209 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 218
TABLE 210 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2017-2019 (USD MILLION) 218
TABLE 211 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY, 2020-2025 (USD MILLION) 219
TABLE 212 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2019 (USD MILLION) 219
TABLE 213 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 219
TABLE 214 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 220
TABLE 215 ASIA PACIFIC: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 220
12.5.1 CHINA 220
12.5.1.1 Increasing international pressure to ban animal testing methods will propel market growth in the coming years 220
TABLE 216 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2017-2019 (USD MILLION) 221
TABLE 217 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY PRODUCT & SERVICE, 2020-2025 (USD MILLION) 222
TABLE 218 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2017-2019 (USD MILLION) 222
TABLE 219 CHINA: IN VITRO TOXICOLOGY TESTING ASSAYS MARKET, BY TYPE,
2020-2025 (USD MILLION) 223
TABLE 220 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2017-2019 (USD MILLION) 223
TABLE 221 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TOXICITY ENDPOINT & TEST, 2020-2025 (USD MILLION) 224
TABLE 222 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2017-2019 (USD MILLION) 224
TABLE 223 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY TECHNOLOGY,
2020-2025 (USD MILLION) 225
TABLE 224 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2017-2024 (USD MILLION) 225
TABLE 225 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY INDUSTRY,
2020-2025 (USD MILLION) 225
TABLE 226 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2017-2019 (USD MILLION) 226
TABLE 227 CHINA: IN VITRO TOXICOLOGY TESTING MARKET, BY METHOD,
2020-2025 (USD MILLION) 226
12.5.2 JAPAN 226

Please contact our Customer Support Center to get the complete Table of Contents